Contradictor in class action fights Monash IVF’s bid to hold on to embryos

Please login to bookmark Close

A contradictor has argued against Monash IVF’s bid for orders allowing it to retain embryos as evidence in a class action, saying the Victorian Supreme Court has no power to make orders inconsistent with the company’s statutory obligation to store embryos for a maximum of five years. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Collingwood hit with racism allegations by ex-First Nations head of strategy

Please login to bookmark Close

The previous head of First Nations strategy of the Collingwood Football Club has brought Fair Work proceedings against their former employer, claiming they were unfairly terminated after making several complaints against CEO Craig Kelly about alleged racially insensitive comments. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Class action attacks ‘false’ logic of AG’s claim GCO a neutral factor in KPMG transfer bid

Please login to bookmark Close

In submissions to the High Court, the applicant in a class action brought on behalf of Arrium shareholders against KMPG has attacked the Attorney-General’s argument that a contingency fee order is a neutral factor in assessing the accounting firm’s bid to move the case from Victoria. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Former EY partner loses $1M share dispute against National Tiles

Please login to bookmark Close

A former EY partner and ousted board member at National Tiles has lost his $1 million claim alleging the company breached implied terms in a contract by requiring him to sign a “draconian, unreasonable and unacceptable” share agreement.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Don’t leave it to the court: Judge urges parties to remember legal costs in settlement talks

Please login to bookmark Close

A judge overseeing a dispute over an employer’s confidential information has urged litigants to remember their legal costs at an early stage of settlement negotiations, rather than leaving it to the court as the “default option”. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

CBA units plead guilty to breaking long service leave laws

Please login to bookmark Close

Two units of the Commonwealth Bank of Australia on Monday pleaded guilty and were hit with $48,000 in penalties for denying staff $1.67 million in long service leave entitlements.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Wellness firm Doll House cops penalty for sham contracting

Please login to bookmark Close

Bondi wellness research company Doll House has copped a $197,000 penalty for terminating three disabled employees and re-engaging them as independent contractors in a ‘sham’ contracting arrangement.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

CrowdStrike outage to spark slew of complex courtroom fights, lawyers say

Please login to bookmark Close

Experts say the chaos of last month’s CrowdStrike outage is likely to spark a flurry of litigation both overseas and at home, including class actions, but lawyers bringing the claims will face significant hurdles.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Collapsed Booktopia courts 100 suitors as administrators reveal $68M in debts

Please login to bookmark Close

Booktopia’s administrators have been given more time to try to sell the online bookseller after receiving 100 expressions of interest, with a judge finding it could yield greater returns for its 170,000 creditors, who are owed a total of $68 million. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

AstraZeneca, Merck face potential class action over heartburn drugs

Please login to bookmark Close

A law firm is investigating claims against the manufacturers of popular heartburn and acid reflux drugs, alleging they could be responsible for causing stomach cancers and kidney failure in approximately 100,000 people.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?